KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Inventory (2016 - 2025)

Historic Inventory for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $6.2 billion.

  • Amgen's Inventory fell 1104.6% to $6.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.2 billion, marking a year-over-year decrease of 1104.6%. This contributed to the annual value of $6.2 billion for FY2025, which is 1104.6% down from last year.
  • Latest data reveals that Amgen reported Inventory of $6.2 billion as of Q4 2025, which was down 1104.6% from $6.3 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's Inventory peaked at $9.5 billion during Q4 2023, and registered a low of $4.0 billion during Q1 2021.
  • Moreover, its 5-year median value for Inventory was $5.0 billion (2023), whereas its average is $5.8 billion.
  • Its Inventory has fluctuated over the past 5 years, first skyrocketed by 9306.29% in 2023, then plummeted by 2647.62% in 2024.
  • Amgen's Inventory (Quarter) stood at $4.1 billion in 2021, then grew by 20.66% to $4.9 billion in 2022, then soared by 93.06% to $9.5 billion in 2023, then decreased by 26.48% to $7.0 billion in 2024, then dropped by 11.05% to $6.2 billion in 2025.
  • Its Inventory stands at $6.2 billion for Q4 2025, versus $6.3 billion for Q3 2025 and $6.6 billion for Q2 2025.